Angiotensin II-induced cardiomyocyte hypertrophy: A complex response dependent on intertwined pathways
Rev Port Cardiol (Engl Ed). 2021 Mar;40(3):201-203.
doi: 10.1016/j.repc.2020.12.009.
Epub 2021 Jan 18.
[Article in
English,
Portuguese]
Affiliations
- 1 Cardiovascular Diseases Research Group, Department of Cardiology, Vall d'Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Departament de Medicina, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Cardiovasculares (CIBERCV), Spain.
- 2 Biomaterials for Regenerative Therapies Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
- 3 Cardiovascular Diseases Research Group, Department of Cardiology, Vall d'Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Departament de Medicina, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address: [email protected].
No abstract available
MeSH terms
-
Angiotensin II*
-
Cardiomegaly / chemically induced
-
Humans
-
Myocytes, Cardiac*
-
Receptor, Angiotensin, Type 1
Substances
-
Receptor, Angiotensin, Type 1
-
Angiotensin II